The global digestive & intestinal remedies market size was valued at USD 21.50 billion in 2024 and is projected to reach USD 27.54 billion by 2030, expanding at a steady CAGR of 4.25% from 2025 to 2030. This market is witnessing significant growth as consumer demand for digestive medicines, including well-known products such as Perenterol, Iberogast, and Dulcolax, continues to rise. A major factor driving this growth is the increasing prevalence of gastrointestinal (GI) disorders worldwide. Common conditions such as inflammatory bowel disease (IBD), constipation, irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD) are becoming more widespread, creating a strong need for accessible, effective, and often over-the-counter (OTC) solutions. Rising awareness about these health concerns has further accelerated the demand for remedies that improve digestive health and overall quality of life, thereby offering substantial opportunities for companies operating in this segment.

The expansion of the market is also being shaped by dietary and lifestyle changes. The growing reliance on convenience-driven diets, including dining out, consumption of packaged foods, and increasing use of processed ingredients, has led to a surge in gastrointestinal issues. Sedentary lifestyles, stress, and irregular eating habits further exacerbate digestive problems, fueling the need for quick and reliable remedies. This shift in consumer behavior has created a favorable environment for businesses to innovate and develop next-generation digestive solutions. Companies are focusing on natural, plant-based formulations, probiotic-rich remedies, and fast-acting medicines that align with consumer preferences for both efficacy and safety. As awareness of digestive health continues to grow, the market is positioned to attract strong investments and sustained development throughout the forecast period.

Key Market Trends & Insights:

• Regional Insights: The North America digestive & intestinal remedies market accounted for 44.92% of the global share in 2024, with the U.S. market holding a dominant position within the region due to higher prevalence rates of gastrointestinal disorders and greater adoption of OTC digestive products.
• By Type: The digestive medicines segment dominated with a 51.98% share in 2024, reflecting strong consumer preference for established pharmaceutical remedies. Meanwhile, the remedies against gastrointestinal complaints segment is expected to show notable growth as more consumers seek specialized treatments for conditions like IBS and GERD.
• By Distribution Channel: The offline segment remained the leading distribution channel in 2024, supported by the presence of pharmacies, drugstores, and retail outlets. It is projected to grow at a CAGR of 4.11% during the forecast period, although online platforms are gaining traction as e-commerce adoption increases.
• By Age Group: The adult & geriatric population dominated with a 62.98% market share in 2024, given their higher susceptibility to gastrointestinal conditions. However, the pediatric segment is projected to experience the fastest growth as awareness of digestive disorders in children increases and parents seek safe, effective remedies tailored for younger patients.

Order a free sample PDF of the Digestive & Intestinal Remedies Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 21.50 Billion
• 2030 Projected Market Size: USD 27.54 Billion
• CAGR (2025-2030): 4.25%
• North America: Largest market in 2024

Key Players

The following are the leading companies in the digestive & intestinal remedies market. These companies collectively hold the largest market share and dictate industry trends.

• Bayer AG
• Johnson & Johnson Services Inc.
• GSK plc.
• Procter & Gamble
• Sanofi
• Boehringer Ingelheim GmbH
• Reckitt Benckiser Group PLC
• Abbott
• Takeda Pharmaceutical Company Limited
• Menarini Group

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global digestive & intestinal remedies market is poised for steady growth, driven by the rising prevalence of gastrointestinal disorders such as IBS, IBD, constipation, and GERD. Changing dietary habits, increased consumption of processed foods, and lifestyle-related factors are further fueling demand for effective digestive solutions. North America remains the leading regional market, while the Asia Pacific and pediatric segments present significant growth opportunities over the forecast period. Among product types, digestive medicines continue to dominate, though remedies targeting gastrointestinal complaints are gaining traction as consumer awareness increases. With innovation focusing on natural formulations, probiotics, and fast-acting OTC medicines, companies have the chance to meet evolving consumer needs. Overall, the market offers strong potential for investment and expansion as awareness of digestive health continues to rise globally.